Visit us on the Internet

www.coventryhealth.com
Notice of Annual Meeting
The annual meeting of shareholders will be held on June 6, 2002, at 9:30 a.m., Daylight Savings Time,
at the offices of Epstein Becker & Green, P.C., 1227 25th Street NW, Washington,
DC
|
Corporate
Headquarters |
Transfer
Agent |
|
|
Investor
Relations |
Corporate Counsel |
Form 10-K
Coventry Health Care has filed an Annual Report on Form 10-K for the year ended December 31, 2001 with the Securities and
Exchange Commission. Shareholders may obtain a copy of this report, without charge, by writing:
Investor Relations Department, Coventry Health Care, 6705 Rockledge Drive, Suite 900, Bethesda, MD 20817
Common Stock
Coventry Health Care common stock is traded on the New York Stock Exchange under the symbol “CVH”.
The following table shows the quarterly range of high and low closing prices of the common stock during the calendar year
indicated
| 2001 | 2000 | ||||||||
| High | Low | High | Low | ||||||
| 1st Quarter | $24.13 | $13.75 | $29.19 | $15.00 | |||||
| 2nd Quarter | $20.59 | $14.78 | $9.06 | $6.94 | |||||
| 3rd Quarter | $25.38 | $18.08 | $14.63 | $8.56 | |||||
| 4th Quarter | $23.19 | $18.29 | $17.63 | $12.75 | |||||
As
of March 12, 2002, Coventry Health Care had approximately 302 shareholders of
record not including
beneficial owners of shares held in nominee name. On March 12, 2002, the
Company’s closing stock price was $25.20.
Dividend Policy
Coventry Health Care has not paid a dividend over the past two years. The Company’s ability to pay dividends is
restricted as discussed in the Liquidity and Capital Resources section of Management’s Discussion
and Analysis of Financial Condition and Results of Operations.
Disclaimer
This annual report contains forward–looking information. These forward–looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward–looking statements may be significantly
impacted by certain risks and uncertainties described herein and in the Company’s Annual Report on Form 10–K filed with the
Securities and Exchange Commission for the year ended December 31, 2001.